ArcaArca
Dashboard
All boards
Loading...
Patients
TasksProgram PerformanceRegistry
Settings
  1. Home
  2. Patients
  3. Patient
All Patients
RM

Martinez, Rosa

MRN-001021

45 y/o · Dr. Sarah Martinez

Diagnosis

Rectal Adenocarcinoma

Stage

Stage IIB

MSS, KRAS G12V, BRAF wild-type, HER2 equivocal

Active

21 open tasks · 11 verified

Last review: Apr 12, 2026 · GI Oncology Tumor Board

Referred

Evaluation

Board Review

Pre-Treatment

Treatment

Surveillance

In pre_treatment for 21 days

Loading care timeline...

Board History & Recommendations

62-year-old with MSI-H stage IIIC colon adenocarcinoma (T4aN2b), R0 resection. Evaluate adjuvant immunotherapy with pembrolizumab (KEYNOTE-177 extrapolation) vs. standard FOLFOX x 3 months (IDEA collaboration). No prior systemic therapy. ECOG 1, no autoimmune history.

Presenting: Dr. David Park

21 days between presentations
70 days between presentations
21 days between presentations
36 days between presentations

Active Tasks

Coordination Notes

Clinical Profile

Diagnosis

Rectal Adenocarcinoma

Stage

Stage IIB

Referring

Dr. Sarah Martinez

Biomarkers

MSSKRAS G12VBRAF wild-typeHER2 equivocal

Clinical Data

Import clinical data from Epic

Pull pathology, imaging, labs, and clinical notes via FHIR